Bempikibart
Bempikibart (ADX-914) is a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and thymic stromal lymphopoietin (TSLP) . Bempikibart can be used for the study of atopic dermatitis and alopecia areata[1].
Product Specifications
CAS Number
[2622254-57-1]
Product Name Alternative
ADX-914
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bempikibart.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
[Bempikibart]
Molecular Weight
(145.745 kDa)
References & Citations
[1]Bick F, et al. Targeting γc family cytokines with biologics: current status and future prospects. MAbs. 2025 Dec;17 (1) :2468312.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Mouse Endothelial cell-specific molecule 1 (Esm1)